Hypermutation in mantle cell lymphoma does not indicate a clinical or biological subentity

Modern Pathology

Volumn 22, Issue 3, 2009, Pages 416-425

  Schraders, Margit ^a   Oeschger, Sabine ^b   Kluin, Philip M ^c   Hebeda, Konnie ^a   Schuuring, Ed ^c   Groenen, Patricia J T A ^a   Hansmann, Martin Leo ^d   Van Krieken, Johan H J M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Mantle cell lymphoma; Somatic hypermutation; VH gene usage

Indexed keywords

KI 67 ANTIGEN;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; GENE FREQUENCY; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; GENE TRANSLOCATION; HEREDITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MANTLE CELL LYMPHOMA; PRIORITY JOURNAL; SOMATIC HYPERMUTATION;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; BLOTTING, SOUTHERN; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 61349139928     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2008.199     Document Type: Article

References (38)

1. Meusers P, Hense J, Brittinger G. Mantle cell lymphoma: diagnostic criteria, clinical aspects and therapeutic problems. Leukemia 1997;11(Suppl 2):S60-S64.
2. Weisenburger DD, Armitage JO. Mantle cell lymphoma - an entity comes of age. Blood 1996;87:4483-4494.
3. Raty R, Franssila K, Joensuu H, et al. Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma. Eur J Haematol 2002;69:11-20.
4. Pinyol M, Hernandez L, Cazorla M, et al. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Blood 1997;89:272-280.
5. Allen JE, Hough RE, Goepel JR, et al. Identification of novel regions of amplification and deletion within mantle cell lymphoma DNA by comparative genomic hybridization. Br J Haematol 2002;116:291-298.
6. Greiner TC, Moynihan MJ, Chan WC, et al. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood 1996;87:4302-4310.
7. Louie DC, Offit K, Jaslow R, et al. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood 1995;86:2892-2899.
8. Camacho FI, Algara P, Rodriguez A, et al. Molecular heterogeneity in mantle cell lymphoma defined by the use of specific VH genes and the frequency of somatic mutations. Blood 2003;101:4042-4046.
9. Kienle D, Krober A, Katzenberger T, et al. VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome. Blood 2003;102:3003-3009.
10. Orchard J, Garand R, Davis Z, et al. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood 2003;101:4975-4981.
11. Thorselius M, Walsh S, Eriksson I, et al. Somatic hypermutation and V(H) gene usage in mantle cell lymphoma. Eur J Haematol 2002;68:217-224.
12. Walsh SH, Thorselius M, Johnson A, et al. Mutated VH genes and preferential VH3-21 use define new subsets of mantle cell lymphoma. Blood 2003;101:4047-4054.
13. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999;94:1840-1847.
14. Hamblin TJ, Davis Z, Gardiner A, et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999;94:1848-1854.
15. Maloum K, Davi F, Merle-Beral H, et al. Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia. Blood 2000;96:377-379.
16. van der Avoort IA, van der Laak JA, Paffen A, et al. MIB1 expression in basal cell layer: a diagnostic tool to identify premalignancies of the vulva. Mod Pathol 2007;20:770-778.
17. Van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia 2003;17:2257-2317.
18. Beishuizen A, Verhoeven MA, Mol EJ, et al. Detection of immunoglobulin kappa light-chain gene rearrangement patterns by Southern blot analysis. Leukemia 1994;8:2228-2236.
19. Tumkaya T, Beishuizen A, Wolvers-Tettero IL, et al. Identification of immunoglobulin lambda isotype gene rearrangements by Southern blot analysis. Leukemia 1996;10:1834-1839.
20. Haralambieva E, Kleiverda K, Mason DY, et al. Detection of three common translocation breakpoints in non-Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin-embedded tissue sections. J Pathol 2002;198:163-170.
21. Specht K, Haralambieva E, Bink K, et al. Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels. Blood 2004;104:1120-1126.
22. Janssen JW, Vaandrager JW, Heuser T, et al. Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32). Blood 2000;95:2691-2698.
23. Schraders M, Pfundt R, Straatman HM, et al. Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization. Blood 2005;105:1686-1693.
24. Siminovitch KA, Bakhshi A, Goldman P, et al. A uniform deleting element mediates the loss of kappa genes in human B cells. Nature 1985;316:260-262.
25. Van Dongen JJ, Adriaansen HJ. Immunobiology of leukemia. In: Henderson ES, Lister TA, Greaves MF (eds). Leukemia, 6th edn. WB Saunders: Philadelphia, 1996;83-130.
26. Flordal TE, Walsh SH, Thorselius M, et al. Mantle cell lymphomas with clonal immunoglobulin V(H)3-21 gene rearrangements exhibit fewer genomic imbalances than mantle cell lymphomas utilizing other immunoglobulin V(H) genes. Mod Pathol 2004;18:331-339.
27. Kuppers R, Klein U, Hansmann ML, et al. Cellular origin of human B-cell lymphomas. N Engl J Med 1999;341:1520-1529.
28. Frater JL, Hsi ED. Properties of the mantle cell and mantle cell lymphoma. Curr Opin Hematol 2002;9:56-62.
29. Hummel M, Tamaru J, Kalvelage B, et al. Mantle cell (previously centrocytic) lymphomas express VH genes with no or very little somatic mutations like the physiologic cells of the follicle mantle. Blood 1994;84:403-407.
30. Bhat NM, Bieber MM, Spellerberg MB, et al. Recognition of auto- and exoantigens by V4-34 gene encoded antibodies. Scand J Immunol 2000;51:134-140.
31. Elagib KE, Borretzen M, Jonsson R, et al. Rheumatoid factors in primary Sjogren's syndrome (pSS) use diverse VH region genes, the majority of which show no evidence of somatic hypermutation. Clin Exp Immunol 1999;117:388-394.
32. He X, Goronzy JJ, Zhong W, et al. VH3-21 B cells escape from a state of tolerance in rheumatoid arthritis and secrete rheumatoid factor. Mol Med 1995;1:768-780.
33. Meffre E, Milili M, Blanco-Betancourt C, et al. Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development. J Clin Invest 2001;108:879-886.
34. Samuels J, Ng YS, Coupillaud C, et al. Human B cell tolerance and its failure in rheumatoid arthritis. Ann N Y Acad Sci 2005;1062:116-126.
35. van der BM, Barendregt BH, van Wering ER, et al. The presence of somatic mutations in immunoglobulin genes of B cell acute lymphoblastic leukemia (ALL-L3) supports assignment as Burkitt's leukemia-lymphoma rather than B-lineage ALL. Leukemia 2001;15:1141-1143.
36. Brauninger A, Goossens T, Rajewsky K, et al. Regulation of immunoglobulin light chain gene rearrangements during early B cell development in the human. Eur J Immunol 2001;31:3631-3637.
37. Bertoni F, Conconi A, Cogliatti SB, et al. Immunoglobulin heavy chain genes somatic hypermutations and chromosome 11q22-23 deletion in classic mantle cell lymphoma: a study of the Swiss Group for Clinical Cancer Research. Br J Haematol 2004;124:289-298.
38. Martinez A, Bellosillo B, Bosch F, et al. Nuclear survivin expression in mantle cell lymphoma is associated with cell proliferation and survival. Am J Pathol 2004;164:501-510.